Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
It´s the first trial to demonstrate the benefits of dual pathway inhibition
Silo enters into commercial evaluation license agreement for next generation liposomes
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
Expanding diagnostics footprint in East India
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
Subscribe To Our Newsletter & Stay Updated
